Cargando…

1370. Prevalence and predictors of post-covid-19 (long covid) in India

BACKGROUND: Long COVID is a condition that occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months from the onset of COVID-19, with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis. This Indian study followed up...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Vignesh, Koshy, Jency Maria, Divyashree, S, Narreddy, Suneetha, Rupali, Priscilla, Sathyendra, Sowmya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678739/
http://dx.doi.org/10.1093/ofid/ofad500.1207
_version_ 1785150435121692672
author Kumar, Vignesh
Koshy, Jency Maria
Divyashree, S
Narreddy, Suneetha
Rupali, Priscilla
Sathyendra, Sowmya
author_facet Kumar, Vignesh
Koshy, Jency Maria
Divyashree, S
Narreddy, Suneetha
Rupali, Priscilla
Sathyendra, Sowmya
author_sort Kumar, Vignesh
collection PubMed
description BACKGROUND: Long COVID is a condition that occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months from the onset of COVID-19, with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis. This Indian study followed up patients after an episode of acute COVID-19 for 1 year after hospital discharge from different parts of India. METHODS: This was a multi-centric bi-directional study among patients with confirmed COVID-19 which assessed patients at different time points, i.e. 6 weeks, 3-6, 6-9 and 9-12 months. Patients aged ≥18 years with laboratory confirmed COVID-19, were recruited and followed up telephonically using standardized surveys for quality of life. Data on demographics, pre-existing co-morbidities, risk factors, signs and symptoms and hospital parameters during acute COVID-19 infection were noted. An effort was made to include people with different severity of COVID-19. Univariate and multivariate analysis were performed to determine predictors of long covid. RESULTS: A total of 315 patients were enrolled (Table 1). Of these, 59.4 were males and 40.6 were females. The mean age was 51.98 ± 14.619 years. At 6 weeks and 12 months, 16.5% and 24% reported continuing symptoms. While shortness of breath was common at each time point, persistent muscle pain and weakness waxed and waned (Figure 1). At 1 year of follow-up, 24% still reported at least 1 troubling symptom and 26% reported > 1 symptom that affected their quality of life i.e., nearly 8% of patients experienced problems in doing their usual activities, 11.7 % were slightly anxious or depressed and few 3.5% experienced slight pain or discomfort. In the multivariable analyses, the severity of disease at baseline (OR 2.330, 95% CI 1.080-5.027) and higher education (OR 0.437, 95% CI 0.241-1.793) seemed to be associated with long COVID. Demographic and clinical characteristics according to the Severity of COVID [Figure: see text] Persisting symptoms of Long COVID [Figure: see text] CONCLUSION: We found that long covid symptoms may be persistent, following an initial recovery from an acute COVID-19 and may also fluctuate or relapse over time. Since symptoms persist in at least 25% of patients for at least 1 year after discharge, we urgently need therapeutic interventions which can improve the quality of life in patients after an acute episode of COVID-19 infection. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10678739
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106787392023-11-27 1370. Prevalence and predictors of post-covid-19 (long covid) in India Kumar, Vignesh Koshy, Jency Maria Divyashree, S Narreddy, Suneetha Rupali, Priscilla Sathyendra, Sowmya Open Forum Infect Dis Abstract BACKGROUND: Long COVID is a condition that occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, usually 3 months from the onset of COVID-19, with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis. This Indian study followed up patients after an episode of acute COVID-19 for 1 year after hospital discharge from different parts of India. METHODS: This was a multi-centric bi-directional study among patients with confirmed COVID-19 which assessed patients at different time points, i.e. 6 weeks, 3-6, 6-9 and 9-12 months. Patients aged ≥18 years with laboratory confirmed COVID-19, were recruited and followed up telephonically using standardized surveys for quality of life. Data on demographics, pre-existing co-morbidities, risk factors, signs and symptoms and hospital parameters during acute COVID-19 infection were noted. An effort was made to include people with different severity of COVID-19. Univariate and multivariate analysis were performed to determine predictors of long covid. RESULTS: A total of 315 patients were enrolled (Table 1). Of these, 59.4 were males and 40.6 were females. The mean age was 51.98 ± 14.619 years. At 6 weeks and 12 months, 16.5% and 24% reported continuing symptoms. While shortness of breath was common at each time point, persistent muscle pain and weakness waxed and waned (Figure 1). At 1 year of follow-up, 24% still reported at least 1 troubling symptom and 26% reported > 1 symptom that affected their quality of life i.e., nearly 8% of patients experienced problems in doing their usual activities, 11.7 % were slightly anxious or depressed and few 3.5% experienced slight pain or discomfort. In the multivariable analyses, the severity of disease at baseline (OR 2.330, 95% CI 1.080-5.027) and higher education (OR 0.437, 95% CI 0.241-1.793) seemed to be associated with long COVID. Demographic and clinical characteristics according to the Severity of COVID [Figure: see text] Persisting symptoms of Long COVID [Figure: see text] CONCLUSION: We found that long covid symptoms may be persistent, following an initial recovery from an acute COVID-19 and may also fluctuate or relapse over time. Since symptoms persist in at least 25% of patients for at least 1 year after discharge, we urgently need therapeutic interventions which can improve the quality of life in patients after an acute episode of COVID-19 infection. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10678739/ http://dx.doi.org/10.1093/ofid/ofad500.1207 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Kumar, Vignesh
Koshy, Jency Maria
Divyashree, S
Narreddy, Suneetha
Rupali, Priscilla
Sathyendra, Sowmya
1370. Prevalence and predictors of post-covid-19 (long covid) in India
title 1370. Prevalence and predictors of post-covid-19 (long covid) in India
title_full 1370. Prevalence and predictors of post-covid-19 (long covid) in India
title_fullStr 1370. Prevalence and predictors of post-covid-19 (long covid) in India
title_full_unstemmed 1370. Prevalence and predictors of post-covid-19 (long covid) in India
title_short 1370. Prevalence and predictors of post-covid-19 (long covid) in India
title_sort 1370. prevalence and predictors of post-covid-19 (long covid) in india
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678739/
http://dx.doi.org/10.1093/ofid/ofad500.1207
work_keys_str_mv AT kumarvignesh 1370prevalenceandpredictorsofpostcovid19longcovidinindia
AT koshyjencymaria 1370prevalenceandpredictorsofpostcovid19longcovidinindia
AT divyashrees 1370prevalenceandpredictorsofpostcovid19longcovidinindia
AT narreddysuneetha 1370prevalenceandpredictorsofpostcovid19longcovidinindia
AT rupalipriscilla 1370prevalenceandpredictorsofpostcovid19longcovidinindia
AT sathyendrasowmya 1370prevalenceandpredictorsofpostcovid19longcovidinindia